Institutional & Family Asset Management’s ARK Genomic Revolution ETF ARKG Stock Holding History

Institutional & Family Asset Management’s Portfolio ARKG Stock Details ARKG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-149	Closed	-$9K	–	766
2021 Q4	$9K	Buy	149 +51	+52%	+$3.53K	﹤0.01%	452
2021 Q3	$7K	Hold	98	–	–	﹤0.01%	600
2021 Q2	$9K	Sell	98 -530	-84%	-$45.1K	﹤0.01%	599
2021 Q1	$56K	Sell	628 -816	-57%	-$80.9K	0.01%	343
2020 Q4	$135K	Buy	1,444 +1,402	+3,338%	+$112K	0.03%	220
2020 Q3	$3K	Hold	42	–	–	﹤0.01%	634
2020 Q2	$2K	Hold	42	–	–	﹤0.01%	672
2020 Q1	$1K	Hold	42	–	–	﹤0.01%	700
2019 Q4	$1K	Buy	42 +1	+2%	+$32	﹤0.01%	789
2019 Q3	$1K	Hold	41	–	–	﹤0.01%	763
2019 Q2	$1K	Hold	41	–	–	﹤0.01%	782
2019 Q1	$1K	Hold	41	–	–	﹤0.01%	770
2018 Q4	$1K	Buy	41 +1	+3%	+$28	﹤0.01%	744
2018 Q3	$1K	Hold	40	–	–	﹤0.01%	786
2018 Q2	$1K	Hold	40	–	–	﹤0.01%	776
2018 Q1	$1K	Buy	+40	New	+$1.08K	﹤0.01%	763

Other funds holding ARKG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

MCMC

Matrix Capital Management Company Portsmouth, New Hampshire $46.3M AUM 114.38% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return

Institutional & Family Asset Management's ARKG Position: Q1 2022 in Review

Institutional & Family Asset Management sold out of ARK Genomic Revolution ETF (ARKG) in Q1 2022, closing a stake of 149 shares — an estimated $9K sold.

Institutional & Family Asset Management first reported a position in ARKG in Q1 2018 and held it in 16 quarters. The position peaked at $135K in Q4 2020. 387 funds tracked by Wall St. Rank hold ARKG as of Q1 2022.

Institutional & Family Asset Management reported no remaining ARK Genomic Revolution ETF position as of Q1 2022 after selling out during the quarter.
Institutional & Family Asset Management sold 149 ARK Genomic Revolution ETF shares in Q1 2022, an estimated $9K.
Institutional & Family Asset Management first reported a position in ARK Genomic Revolution ETF in Q1 2018 and held it in 16 quarters.
Institutional & Family Asset Management's ARK Genomic Revolution ETF position peaked at $135K in Q4 2020.
387 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2022.

Based on Institutional & Family Asset Management's 13F filing for Q1 2022, filed 11 May 2022.